DPTE-BetaBag
The DPTE-BetaBag®, the gold standard for ultra-clean transfer, a simple, validated solution that offers huge benefits along the production chain in the crucial stage of leaktight transfer of aseptic and/or products.
DPTE® transfer system: an ingenious solution
Secure leaktight transfer of material in and out of an isolator, a RABS, a biosafety cabinet or a cleanroom is safely carried out with the completely validated and patented DPTE® transfer system. The DPTE® Alpha port is mounted on a support (e.g. an isolator surface) while the Beta unit is movable and seals off a container, transfer isolator or other suitable device. Successive bi-directional transfer operations can be done without breaking the integrity of the sterile or toxic environment contained within the alpha and beta components.
The DPTE® Alpha port and Beta accessories are available in 4 standard sizes: 105, 190, 270 and 350. The Alpha port is available in the DPTE®-XS or DPTE®-XO model.
DPTE® Beta parts include DPTE-BetaBags®, PE containers, re-usable autoclavable containers and plastic tubing.
DPTE-BetaBags® are supplied ready-to-sterilize and pre-sterilized, for a variety of applications including transfer of liquid and powder, caps, stoppers, vials, environmental monitoring kits, cleaning consumables, disposal of waste products etc. Manufactured in ultra-clean production conditions, each bag is rigorously tested before release. All stages of the manufacturing process are examined and documented in compliance with GMP, giving significant time and cost savings for end-users.
Contact Details:
Getinge La CalhèneWebsite:www.getinge.comE-mail: marketing-contact.glc@getinge.com
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Innovative Solutions in Pre-Filled Syringes for Biologics and Ophthalmic Applications
May 5th 2025Don't miss this webinar delving into: - How to streamline the selection of the primary container and delivery device - How to overcome silicone challenges in PFSs - How to enhance the delivery of highly viscous drug formulation
Solving the Silicone Challenge in Pre-fillable Syringes
May 5th 2025The release of subvisible silicone particles and the risks associated with silicone oil droplets are major factors that can compromise the safety and efficacy of sensitive drugs. Download this white paper and discover how Stevanato Group's innovative syringe platform answers this challenge.
